Calendar

Rundown of all the drugs approved in 2023 with detailed analysis: why it matters for patients, the companies that brought them to market, and more.

The biggest biopharma industry conference of the year. A two-day event hosted by Endpoints alongside coverage of JPM: Wall-to-wall news stories, coverage via our event in San Francisco featuring panels and fireside chats from leading figures in R&D and business, and industry newsmakers. Make sense of the year ahead and learn the most important scientific and business trends facing the industry and more.

The biopharma VC world's most prolific dealmakers, ranked by number of deals and the dollars they put to work. Featuring an interactive data set.

An Endpoints Day focused on drug discovery, featuring a panel session hosted by an Endpoints journalist with more sessions to be announced. This event will focus on research pipelines, emerging drug targets and the inflection point of research to development.

All the news from the American Association for Cancer Research conference in San Diego, California. This is an R&D-focused conference that always generates a handful of major headlines on the drugs of tomorrow.

The cell & gene landscape is ripe with big promises backed by evolving tech, fresh talent with splashes of funding and M&A catching headlines as therapies roll forward. But how are the experts doing it in 2024? What are the biggest scientific advancements — and best strategies for investment, manufacturing and commercial access? Join us as we explore the field’s future — and examine past safety issues — with a series of sessions geared toward furthering cell & gene drug development.

The Financial Times US Pharma and Biotech Summit returns to New York in May 2024, partnered with Endpoints News for the first time. The event will gather biopharma leaders, regulators, investors and scientists to share unique insights about the year ahead and discuss the most important trends affecting the industry, and the country.

ASCO never fails to make its mark as the oncology conference to watch, no matter which way the data are. What pipelines are going to swell — or fade — as the readouts surface? Is a reshaping of the cancer landscape in the cards this year or will slow and steady win the race? Join Endpoints News’ ASCO experts panel to recap the data you don’t want to miss — and more.

The biotech industry's annual trade conference in San Diego, California. We assess where we are as an industry and break down the future trends in biopharma. Featuring conversations with VCs and a focus on what the mid-year outlook holds.

Our special report profiles the achievements of LGBTQ+ biopharma execs and scientific leaders who are influencing the industry.

The most anticipated cancer conference of the year, with practice-changing clinical data and a large corporate presence eyeing one of the biggest categories of drug R&D and commercial sales. We have a team on the ground covering the hottest news out of ASCO.

Cannes has become one of the big hub events for media, marketing and advertising. We report on the marketing deals and trends that will drive how drugs are advertised and sold to patients.

Following the landmark approvals of two new Alzheimer's drugs, Endpoints will be in Philadelphia to cover new scientific advances in Alzheimer's, the next drugs in the pipeline, and the commercial future for the field.

Following the landmark approvals of two new Alzheimer's drugs, Endpoints will be in Philadelphia to cover new scientific advances in Alzheimer's, the next drugs in the pipeline, and the commercial future for the field.

The European Society of Cardiology — practice-changing research is revealed along with clinical updates to drugs in development. Endpoints is there in person covering the news as it breaks real time in London, UK.

An exclusive gala dinner with drinks and networking — and you get to meet the future of biotech.

Profiles of the top 11 private biotechs in pursuit of new drugs and who are pushing the envelope with powerful new technologies.

Our event on the ground at ESMO — we break down what drugs in the cancer pipeline are the ones to watch, and which ones didn’t make it past the goal line. Join our expert panel, fireside chat and more.

Europe’s headlining cancer conference lands in Barcelona, Spain this year as major medical updates on drugs in the pipeline are given out. Endpoints covers the readouts in real time.

Who are the women leading and influencing biopharma? Each year we seek out the up-and-comers moving the industry forward. Our in-depth profiles establish their stories into the fabric of an industry that isn’t changing fast enough to keep up with gender diversity.

AI is everywhere in the biopharma industry. Every company, from the biggest global pharma to the tiniest biotech, is experimenting with the technology. But what’s hype, and what’s reality? We’re bringing together AI evangelists and skeptics alike to chart out the places AI is most likely to push the industry forward.

CPhI brings together members of the drug supply chain, including many of the critical pharma service companies that drive the supply and production of drugs.

The future leaders of biotech — many of whom are already reaching for the top of their game. These are the 20 executives under 40 who are making an impact on the industry, have raised serious capital, or are moving innovative, exciting companies forward.

Endpoints will be at one of the biggest scientific conferences for AI, with 10,000+ attendees reviewing cutting-edge research in AI x biology.